Enbrel 50 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26FCS0D
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,283
Award facts
- Contract value 100% obligated
- $11,283.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,283.00 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on December 1, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and running through December 2026. The contract is non-competitive with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 2, 2025.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal military and veteran healthcare procurement through its extensive portfolio of brand-name and generic medications, vaccines, and specialty medical supplies. The SPE2DX IDC enables the company to supply pharmaceutical products globally to support military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. This delivery order for Enbrel, a biologic immunosuppressant used to treat rheumatoid arthritis and other autoimmune conditions, reflects the company's role in supporting the comprehensive pharmaceutical needs of the Department of Defense medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCS0D?
SPE2DR26FCS0D was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FCS0D worth?
The government has obligated $11,283 on SPE2DR26FCS0D.
Is contract SPE2DR26FCS0D an order under another contract?
Yes. SPE2DR26FCS0D is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCS0D competed?
The extent of competition for SPE2DR26FCS0D was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award